# Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management

> **NCT07394725** · PHASE1 · COMPLETED · sponsor: **District Headquarters Teaching Hospital Sahiwal** · enrollment: 250 (actual)

## Conditions studied

- Pre-term Premature Rupture of Membranes

## Interventions

- **DRUG:** Erythromycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT07394725
- **Lead sponsor:** District Headquarters Teaching Hospital Sahiwal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07394725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07394725, "Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07394725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*